- Home
- DNLI vs PLNT Comparison
DNLI vs PLNT Comparison
Compare DNLI & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | PLNT |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.9B |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DNLI | PLNT |
|---|---|---|
| Price | $20.56 | $41.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $34.33 | ★ $107.46 |
| AVG Volume (30 Days) | 1.3M | ★ 1.9M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,324,144,000.00 |
| Revenue This Year | N/A | $19.22 |
| Revenue Next Year | $408.85 | $11.66 |
| P/E Ratio | ★ N/A | $38.47 |
| Revenue Growth | N/A | ★ 12.06 |
| 52 Week Low | $13.14 | $37.03 |
| 52 Week High | $27.30 | $114.26 |
Technical Indicators
Market Signals| Indicator | DNLI | PLNT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 23.67 |
| Support Level | N/A | $37.03 |
| Resistance Level | N/A | $54.24 |
| Average True Range (ATR) | 0.00 | 1.84 |
| MACD | 0.00 | -0.82 |
| Stochastic Oscillator | 0.00 | 8.02 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.